Emerging drug class may enhance red blood cell production in anemic patients

By determining how corticosteroids act to increase production of red blood cell progenitors, researchers have identified a class of drugs that may be beneficial in treating some erythropoietin-resistant anemias. One such anemia is Diamond-Blackfan anemia (DBA), which is frequently treated with corticosteroids, despite their severe side-effects. The identified class of drugs may be able to treat other anemias, including those resulting from trauma, sepsis, malaria, kidney dialysis and chemotherapy.

Read the whole article on Science Daily

More from Science Daily